Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Schedule of number and weighted average GDFV of option granted

Three months ended

March 31, 2023

RSUs Granted (000's)

Weighted Average GDFV

Series A Qurate Retail common stock, subsidiary employees (1)

935

$

0.89

Series A Qurate Retail common stock, Qurate Retail employees and directors (2)

553

$

1.51

Series A Qurate Retail common stock, Qurate Retail President and CEO (3)

1,869

$

1.51

Series B Qurate Retail common stock, Qurate Retail Chairman of the Board (4)

353

$

5.51

(1) Grant vests equally over three years.
(2) Grants mainly vest one year from the month of grant, subject to the satisfaction of certain performance objectives.
(3) Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with the employment agreement of our President and Chief Executive Officer.
(4) Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with our Chairman’s employment agreement.  

Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors

Weighted

Weighted

Series A

Average

Series B

Average

(000's)

GDFV

(000's)

GDFV

RSUs outstanding at January 1, 2023

 

23,166

$

5.09

327

$

4.95

Granted

 

3,357

$

1.34

353

$

5.51

Vested

 

(5,544)

$

6.37

(327)

$

4.95

Forfeited/Cancelled

 

(1,850)

$

5.71

$

RSUs outstanding at March 31, 2023

 

19,129

$

4.00

353

$

5.51

 

Common Class A  
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

    

    

    

Weighted

    

Aggregate

 

average

intrinsic

Series A

remaining

value

(000's)

WAEP

life

(millions)

Options outstanding at January 1, 2023

 

32,914

$

8.78

Granted

 

$

Exercised

 

(14)

$

2.17

Forfeited/Cancelled

 

(4,016)

$

12.90

Options outstanding at March 31, 2023

 

28,884

$

8.21

 

2.9

years

$

Options exercisable at March 31, 2023

 

18,954

$

9.61

 

2.3

years

$

Common Class B  
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

    

    

    

Weighted

    

Aggregate

 

average

intrinsic

Series B

remaining

value

(000's)

WAEP

life

(millions)

Options outstanding at January 1, 2023

 

2,221

$

12.25

Granted

 

$

Exercised

 

$

Forfeited/Cancelled

(1,498)

$

12.20

Options outstanding at March 31, 2023

 

723

$

12.35

 

1.6

years

$

Options exercisable at March 31, 2023

 

723

$

12.35

 

1.6

years

$